"A":
«Pharmaceutical products / Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products»
HS code: 3002
From | |
Direction | |
To | |
Period | |
Selection products |
Period | Total |
---|---|
4th quarter, 2014 | <hidden> |
1st quarter, 2015 | <hidden> |
2nd quarter, 2015 | <hidden> |
3rd quarter, 2015 | <hidden> |
4th quarter, 2015 | <hidden> |
Total: | <hidden> |
Period | Weight, tons. |
---|---|
4th quarter, 2014 | <hidden> |
1st quarter, 2015 | <hidden> |
2nd quarter, 2015 | <hidden> |
3rd quarter, 2015 | <hidden> |
4th quarter, 2015 | <hidden> |
Total: | <hidden> |
Group product | Q4 2014 | Q4 2015 | Ch. | ∑ (Q4 2014-Q4 2015) | Ratio |
---|---|---|---|---|---|
06 300210: Immune serum, other blood fractions and immunological products | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300211: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300212: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300213: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300214: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300215: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300219: | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300220: Vaccines for human medicine | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300230: Vaccines for veterinary medicine | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 300290: Other | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
Total: | <hidden> | <hidden> | <hidden> |
№ | Country | ∑ (Q4 2014-Q4 2015) | Ratio |
---|---|---|---|
1 | Kazakhstan | <hidden> | <hidden>% |
2 | India | <hidden> | <hidden>% |
3 | Ukraine | <hidden> | <hidden>% |
4 | Latvia | <hidden> | <hidden>% |
5 | Belarus | <hidden> | <hidden>% |
6 | Armenia | <hidden> | <hidden>% |
7 | Kyrgyzstan | <hidden> | <hidden>% |
8 | Tajikistan | <hidden> | <hidden>% |
9 | Panama | <hidden> | <hidden>% |
10 | Thailand | <hidden> | <hidden>% |
11 | Azerbaijan | <hidden> | <hidden>% |
12 | Moldova | <hidden> | <hidden>% |
13 | Slovakia | <hidden> | <hidden>% |
14 | Lithuania | <hidden> | <hidden>% |
15 | Kenya | <hidden> | <hidden>% |
... | ... | ... | ... |
18 | Germany | <hidden> | <hidden>% |
19 | United Kingdom | <hidden> | <hidden>% |
20 | Italy | <hidden> | <hidden>% |
21 | Croatia | <hidden> | <hidden>% |
22 | Oman | <hidden> | <hidden>% |
... | ... | ... | ... |
The total for all countries: | <hidden> | 100% |
№ | Region | ∑ (Q4 2014-Q4 2015) | Ratio |
---|---|---|---|
1 | Saratovskaya oblast | <hidden> | <hidden>% |
2 | Moskva | <hidden> | <hidden>% |
3 | Sankt-Peterburg | <hidden> | <hidden>% |
4 | Novosibirskaya oblast | <hidden> | <hidden>% |
By all regions: | <hidden> | 100% |